20.03.2024 16:18 | ROAD, PYX, POLB | EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake | Alliance |
20.03.2024 07:00 | POLB | POLB 001 US Patent Update | RNS |
22.02.2024 07:00 | POLB | Director/PDMR Shareholding | RNS |
19.02.2024 13:42 | POLB | Director Share Purchase | RNS |
15.02.2024 16:02 | DEC, POW, POLB | TRADING UPDATES: Diversified Energy offers dividend alternative | Alliance |
15.02.2024 07:00 | POLB | Board Role Change and Launch of EIP | RNS |
12.02.2024 19:44 | ATY, NTQ, KAT | TRADING UPDATES: Katoro Gold launches fundraising, eyes board shake-up | Alliance |
12.02.2024 07:00 | POLB | Market Opportunity for POLB 001 for CRS | RNS |
17.01.2024 13:58 | POLB | Poolbeg Pharma hails POLB 001'S potential to treat CRS | Alliance |
17.01.2024 07:00 | POLB | Further data shows POLB001 potential in cancer CRS | RNS |
20.12.2023 20:00 | BELL, ADT1, RAI | TRADING UPDATES: K3 Business says cash balances ahead of forecast | Alliance |
20.12.2023 07:00 | POLB | RSV AI Drug Candidate Analysis Update | RNS |
11.12.2023 07:00 | POLB | POLB 001 Data Presented at ASH | RNS |
30.11.2023 07:00 | POLB | Directorate Change | RNS |
21.11.2023 14:39 | TRR, DNE, UKOG | TRADING UPDATES: Poolbeg hails approval; EDX links with Thermo Fisher | Alliance |
21.11.2023 07:00 | POLB | Immunomodulator II patent granted in Japan | Reach |
16.11.2023 07:00 | POLB | POLB 001 LPS Trial Data to be Presented at IUIS | Reach |
09.11.2023 16:57 | POLB | IN BRIEF: Poolbeg Pharma appoints former Amryt executives to team | Alliance |
09.11.2023 07:00 | POLB | Former Amryt Pharma Leadership Team join Poolbeg | RNS |
03.11.2023 07:05 | POLB | POLB001 Data to be Presented at ASH Annual Meeting | RNS |
01.11.2023 07:00 | POLB | POLB 001 Oncology Programme Update Meeting | RNS |
26.10.2023 07:00 | POLB | SAB Endorses Influenza Drug Targets | Reach |
17.10.2023 10:49 | POLB | Poolbeg Pharma shares up on metabolic drug collaboration agreement | Alliance |
17.10.2023 07:00 | POLB | Poolbeg Partners with a Nasdaq-Listed Biopharma | RNS |
02.10.2023 14:20 | CAV, OHG, OTV2 | EARNINGS AND TRADING: Kingswood cuts outlook; Poolbeg in patent joy | Alliance |
29.09.2023 07:00 | POLB | Favourable Conclusion of Patent Opposition | RNS |
22.09.2023 20:37 | POLB, BMS, AGY | TRADING UPDATES: Braemar investigation to end; Marula reports delay | Alliance |
20.09.2023 07:00 | POLB | Immunomodulator I Patent Portfolio Strengthened | Reach |
19.09.2023 14:42 | UMR, BEG, COBR | TRADING UPDATES: Chill Brands unphased by regulations; Cobra inks deal | Alliance |
19.09.2023 07:00 | POLB | Immunomodulator I Patent Opposition Withdrawal | RNS |
13.09.2023 14:41 | PPHC, POLB, MTEC | EARNINGS: Frontier Developments turns to loss; Poolbeg optimistic | Alliance |
13.09.2023 07:00 | POLB | Interim results for the six months to 30 June 2023 | RNS |
29.06.2023 16:52 | POLB | Poolbeg Pharma makes "significant" influenza breakthrough with AI | Alliance |
29.06.2023 07:00 | POLB | AI led programme identifies influenza drug targets | RNS |
22.06.2023 13:38 | POLB | IN BRIEF: Poolbeg oral vaccination programme moves forward | Alliance |
22.06.2023 07:00 | POLB | Oral Vaccine Programme Moves Forward | RNS |
24.05.2023 07:00 | POLB | Board Appointment | RNS |
11.05.2023 14:27 | POLB | Results of Annual General Meeting | RNS |
04.05.2023 16:11 | WPS, VID, UPR | UK shareholder meetings calendar - next 7 days | Alliance |
12.04.2023 07:00 | POLB | Annual Report & AGM Notice | RNS |
30.03.2023 07:00 | POLB | Results for the year ended 31 December 2022 | RNS |
10.03.2023 07:00 | POLB | Notification of Major Holdings | RNS |
09.03.2023 15:51 | SDR, POLB | Notification of Major Holdings | RNS |
08.03.2023 18:24 | MXC, MYX, SDX | TRADING UPDATES: Poolbeg patent boost; Resolute Mining resource up | Alliance |
08.03.2023 07:00 | POLB | POLB 001 patent portfolio strengthened | Reach |
02.03.2023 14:47 | VTU, TXP, TLY | TRADING UPDATES: Cordiant Digital hails portfolio firm's deal with AMC | Alliance |
02.03.2023 11:14 | VRCI, TLY, POLB | AIM WINNERS & LOSERS: Metal Tiger goes into the Strata but out of AIM | Alliance |
02.03.2023 11:05 | POLB | Second Price Monitoring Extn | RNS |
02.03.2023 11:00 | POLB | Price Monitoring Extension | RNS |
02.03.2023 07:00 | POLB | Positive Results POLB001 LPS Human Challenge Trial | RNS |
16.01.2023 16:26 | ACPE, FARN, LBOW | TRADING UPDATES: Tungsten West 'largest Western tungsten producer' | Alliance |
16.01.2023 07:00 | POLB | Strategic expansion of POLB 001 into oncology | RNS |
09.01.2023 14:14 | POLB | Poolbeg Pharma says initial POLB 001 data shows positive response
| Alliance |
09.01.2023 09:05 | POLB | Second Price Monitoring Extn | RNS |
09.01.2023 09:00 | POLB | Price Monitoring Extension | RNS |
09.01.2023 07:00 | POLB | Positive Initial Data Analysis in POLB 001 Trial | RNS |
22.12.2022 10:47 | POLB | EQS-News: Poolbeg Pharma identifies new RSV drug candidates | EQS |
21.12.2022 19:20 | POLB, CNR, GCAT | TRADING UPDATES: Atlantis Japan underperforms; Bellevue lowers payout | Alliance |
21.12.2022 07:00 | POLB | Poolbeg identifies novel RSV drug candidates | RNS |
15.12.2022 09:48 | POLB | EQS-News: Poolbeg Pharma makes 'interesting addition to existing collaboration' | EQS |
14.12.2022 21:54 | HE1, RMMC, AET | TRADING UPDATES: Poolbeg acquires license; Afentra expects PSA delay | Alliance |
14.12.2022 07:00 | POLB | Metabolic diseases oral delivery licence signed | RNS |
12.12.2022 14:05 | POLB | Second Price Monitoring Extn | RNS |
12.12.2022 14:00 | POLB | Price Monitoring Extension | RNS |
12.12.2022 11:59 | POLB | EQS-News: Poolbeg Pharma receives initial results from human challenge clinical study | EQS |
12.12.2022 07:00 | POLB | POLB 001 LPS human challenge trial completed | RNS |
02.12.2022 19:33 | AST, SLE, ARV | TRADING UPDATES: Time Out eyes Riyadh; MTI Wireless wins deal | Alliance |
29.11.2022 07:00 | POLB | Influenza AI model build completed | Reach |
21.11.2022 11:35 | POLB | EQS-News: Poolbeg Pharma wins first non-dilutive grant funding | EQS |
18.11.2022 14:00 | POLB | Price Monitoring Extension | RNS |
17.11.2022 14:05 | POLB | Second Price Monitoring Extn | RNS |
17.11.2022 14:00 | POLB | Price Monitoring Extension | RNS |
17.11.2022 07:00 | POLB | Capital Markets Day | RNS |
15.11.2022 17:25 | POLB | Poolbeg Pharma wins funding for oral vaccine development | Alliance |
15.11.2022 10:36 | POLB | Poolbeg-led consortium awarded EUR 2.3m grant | RNS |